Convening of Annual General Meeting of Shareholders On

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
115
Convening of Annual General Meeting of Shareholders

On the initiative and following the resolution of the Board of Panevezio statybos trestas AB, the Annual General Meeting of Shareholders of Panevezio statybos trestas AB (address of registered office P. Puzino Str. 1, Panevezys, company code 147732969) is convened on 21 April 2017.

The place of the meeting - the meeting room of Panevezio statybos trestas AB at P. Puzino Str. 1, Panevezys.

The beginning of the meeting – at 11:00 (registration shall start at 10:30).

The record day of the meeting shall be 13 April 2017 (only the persons who at the end of the record day of the General Meeting of Shareholders shall be on the shareholder list of the company, or the persons who are a proxy for them, or the persons with whom an agreement on the transfer of voting rights has been concluded, shall have the right to participate and vote at the General Meeting of Shareholders).

The record day of the rights shall be 8 May 2017 (the shareholders shall use their property rights resulting from the resolutions adopted at the General Meeting of Shareholders in proportion to the number of shares hold at the end of the record day of the rights).

The meeting agenda:

  1. Audit opinion on the Financial Statements and Annual Report of the company for the year 2016.
  2. Annual Report of the company for the year 2016.
  3. Approval of a set of Financial Statements of the company for the year 2016.
  4. Appropriation of profit (loss) of the company for the year 2016.
  5. Election of members for the audit committee. 

The company shall not provide possibilities to participate and vote at the meeting using any means of electronic communications.

Draft resolutions on the items of the agenda, any documents to be presented to the General Meeting of Shareholders and any information related to realisation of the shareholders’ rights shall be published on the website of the company at www.pst.lt under the menu item Investor Relations not later than 21 days before the meeting date. The shareholders shall also be granted access to the information thereof at the secretary’s office at the registered office of the company (P. Puzino Str. 1, Panevezys) from 7:30 till 16:30. Telephone number for inquiries: (+370 45) 505 508.

The shareholders who hold shares carrying at least 1/20 of all votes may propose additional items to be included in the agenda and present a draft resolution of the General Meeting of Shareholders for each proposed additional agenda item or, in case no resolution is to be adopted, give an explanation. Any proposals for additional items of the agenda shall be submitted in writing or by e-mail.

The proposals in writing shall be delivered to the secretary’s office or sent by registered mail to the following address: Panevezio statybos trestas AB, P. Puzino Str. 1, LT-35173, Panevezys. The proposals by e-mail shall be sent to the following e-mail address: pst@pst.lt.

Any proposals for additional items of the agenda shall be presented before 16:00 on 7 April 2017. In the event new items are added to the meeting agenda, not later than 10 days before the meeting date the company shall inform about the additions thereof using the same means as were used for convening the meeting.

The shareholders who hold shares carrying at least 1/20 of all votes may propose new draft resolutions on the items that are on or to be included in the agenda, additional candidates for the members of the company bodies and the audit company. The proposals thereof may be presented in writing or by e-mail.

The proposals in writing before 8:00 on 21 April 2017 may be delivered (on work days) to secretary’s office or sent by registered mail to Panevezio statybos trestas AB, P. Puzino Str. 1, LT-35173, Panevezys. The proposals presented in writing shall be discussed during the meeting provided they have been received at the company before 8:00 on the meeting day (21 April 2017). Any proposals in writing may be presented during the meeting after the chairman of the meeting reads the agenda out but not later than the meeting starts working on the agenda items.

Any proposals to be delivered by e-mail are to be sent to pst@pst.lt. The proposals received to the e-mail address thereof before 8:00 on 21 April 2017 shall be discussed during the meeting. 

The shareholders shall be entitled to present their questions related to the agenda items to the company in advance. The questions may be sent by the shareholders by e-mail to pst@pst.lt not later than 3 working days before the meeting date. The company shall answer the questions thereof by e-mail before the meeting. The company shall not deliver the answer to any question of the shareholders in person provided the relevant information is published on the website of the company at http://www.pst.lt.

When registering for participation at the meeting, the shareholders or their proxies shall present a document which is a proof of their personal identity. The proxies to the shareholders shall present their proxies certified following the prescribed procedure. The proxy issued by a legal person shall be certified by a Notary Public. The proxy issued in a foreign country shall be translated into Lithuanian and legalised following the procedure prescribed by law. The proxy may be given the authority by more than one shareholder and vote in a different manner based on the instructions given by each shareholder. The company has no special form for the proxy.

The shareholder may, using the means of electronic communications, authorize some other natural or legal person to participate and vote at the meeting on behalf of the shareholder. Such proxy shall require no certification by a Notary Public. The proxy issued by the means of electronic communications shall be certified by the electronic signature of the shareholder created using any safe electronic signature software and attested by the qualified certificate valid in the Republic of Lithuania. Both the proxy and the notification shall be in writing. The shareholder shall notify the company about the proxy issued by the means of electronic communications by e-mail to pst@pst.lt not later than 16:00 on the last working day before the meeting date. The electronic signature shall be affixed on the proxy and notification but not on the letter sent by e-mail.  When sending the notification to the company, the shareholder shall refer to the internet address to be used for the purpose of free downloading of electronic signature verification software. In case the shares hold by the shareholder are kept on a few securities accounts, the shareholder may authorise a separate proxy to participate and vote at the General Meeting of Shareholders in accordance with the rights carried by the shares kept in each securities account. In that case, any instructions given by the shareholder shall be valid only for one General Meeting of Shareholders. 

The shareholder who holds the shares of the company acquired in his name, however for the interests of other persons, before voting at the General Meeting of Shareholders shall disclose to the company the identity of the end client, the number of voting shares and the content of given voting instructions or any other explanation related to participation and voting at the General Meeting of Shareholders agreed with the client. The shareholder may vote in a different manner using one part of his shares carrying votes and the other part of shares carrying votes. 

A shareholder or his proxy may vote in advance in writing by filling in the general ballot paper. Not later than 21 days before the meeting date the form of the general ballot paper shall be published on the website of the company at http://www.pst.lt under the menu item Investor Relations . In case a shareholder submits a written request, not later than 10 days before the meeting date the company shall send a general ballot paper by registered mail or deliver it in person against signature of receipt. The filled in general ballot paper shall be signed by the shareholder or his proxy. In case the general ballot paper is signed by the proxy, the document validating the voting right shall be attached to it. The filled in general ballot paper with the attached documents (if required) shall be delivered by registered mail to the secretary’s office at Panevezio statybos trestas AB, P. Puzino Str. 1, LT- 35173, Panevezys not later than the last working day before the meeting date.   

The following information and documents shall be published on the website of the company at http://www.pst.lt under the menu item Investor Relations throughout the entire period starting not later than 21 days before the meeting date:  

-  notice of convening the meeting; 

-  total number of company shares and number of voting shares on the date of convening the meeting;  

-  draft resolutions on the items of the agenda and other documents to be presented to the meeting; 

-  form of general ballot paper.

Dalius Gesevicius

Managing Director

Phone: (+370 45) 505 503

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 938

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 289

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 309

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 261

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sonic Partners with Obsessed Garage for Home Garage Solutions

Updated Category News Views 147

Sonic Teams Up with Obsessed Garage to Transform Home Garages Sonic, a front-runner in delivering high-quality tool solutions and equipment, has recently announced an exciting partnership with Obsessed Garage. This collaboration aims to cater to home garage enthusiasts who demand tools and storage solutions that match the quality standards utilized by professionals in the...

Continue Reading
Investors of Sun Communities, Inc. Urged to Act Before Deadline

Updated Category News Views 167

Important Update for Sun Communities, Inc. Investors There is a significant call to action for investors of Sun Communities, Inc. as a class action lawsuit has been filed against the company, urging those affected to act promptly. This is a crucial moment for investors who purchased securities from the company during a specific period. Legal representation is being...

Continue Reading
XOMA Stock Reaches New Heights: Key Developments and Insights

Updated Category News Views 67

XOMA Stock Performance Overview XOMA Ltd's stock has recently made headlines by reaching a remarkable 52-week high, with shares trading at an impressive $30.49. This achievement not only signifies a significant milestone for the company but also highlights a robust year-over-year growth that can't be overlooked. Investors have observed a substantial increase of 73.82% in...

Continue Reading
Evolv Technologies Faces Turmoil with Executive Departures

Updated Category News Views 230

Evolv Technologies Faces Turmoil with Executive Departures Evolv Technologies Holdings (NASDAQ: EVLV) is navigating turbulent times following the resignation of its Chief Financial Officer, Mark Donohue. His departure comes amid serious allegations of improper revenue recognition practices that have raised questions about the company's integrity and financial health....

Continue Reading
Editas Medicine: Financial Insights and Market Strategies Revealed

Updated Category News Views 56

Editas Medicine Maintains Price Target Amidst Financial Developments Recently, Leerink Partners reaffirmed a Market Perform rating for Editas Medicine (NASDAQ: EDIT), keeping a price target steady at $8.00. This decision comes closely after the company announced a substantial financing agreement with DRI Healthcare Trust. Under this agreement, Editas is set to receive an...

Continue Reading